Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion description "[By using the band intensity ratios of SCCA2 to beta-actin, with a positive cut-off value of > or = 0.4, the positive rates of the SCCA2 mRNA expression in peripheral blood were found to be 82% (41/50), 60% (30/50), 48% (24/50), and 36% (18/50) in the cancer, dysplasia, basal cell hyperplasia, and control groups, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion evidence source_evidence_literature NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion SIO_000772 19125792 NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion wasDerivedFrom befree-20140225 NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion wasGeneratedBy ECO_0000203 NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- befree-20140225 importedOn "2014-02-25" NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.